Personalized Nutrition AI Platforms Market Size & Share 2026-2035

Personalized Nutrition AI Platforms Market Size

The personalized nutrition AI platforms market was valued at USD 2.10 billion in 2025, is projected to reach USD 2.67 billion in 2026, and is expected to grow at a 27.5% CAGR (2026-2035) to reach USD 23.84 billion by 2035.

The personalized nutrition AI platforms market is moving from consumer-led dietary coaching toward a broader health-management layer that links biological, behavioral, and food-intake data with actionable interventions. Diabetes affects 40.1 million Americans, reinforcing the scale of diet-modifiable health needs that platforms can address through consumer, clinical, employer, and payer channels ^{[1]Centers for Disease Control and Prevention. "National Diabetes Statistics Report." cdc.gov}.

Personalized Nutrition AI Platforms Market Trends, Growth Drivers & GMI Forecast Outlook

Demand is being reshaped by the intersection of metabolic-risk management, institutional digital-health procurement, and AI architectures capable of interpreting increasingly diverse biological and behavioral inputs. The outlook depends on whether platforms can translate greater personalization into clinically credible, economically viable engagement models.

Key Drivers

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Metabolic health is creating a durable demand base because nutrition interventions can be positioned before disease progression, rather than solely after diagnosis. For providers and employers, the commercial appeal lies in identifying risk cohorts, translating complex data into practical food guidance, and maintaining interventions between clinical encounters. Platforms that can evidence adherence and outcomes are better positioned to move from wellness budgets into condition-management pathways.

Institutional purchasers are also changing the market's revenue logic. Enterprise and payer procurement can create longer contract cycles and broader covered populations than direct subscriptions, but buyers increasingly expect interoperability, measurable outcomes, and operational support. This shifts vendor competition away from consumer acquisition alone and toward implementation quality, data governance, and clinical workflow fit.

LLM-enabled interfaces and multi-omics inputs are expanding the scope of personalization beyond static calorie targets or questionnaire-based recommendations. The strongest platforms combine conversational guidance with evidence-led interpretation of biomarkers, wearable signals, and dietary behavior. That capability can improve relevance at the point of decision, but it also raises the importance of clinical safeguards and transparent recommendation logic.

Key Restraints

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Retention remains the principal weakness of direct-to-consumer models. Once users have received initial recommendations, platforms must prove that ongoing coaching continues to create value through changing health conditions, new data inputs, or improved outcomes. The restructuring pressure reported among premium personalized-nutrition providers illustrates the commercial consequences when engagement does not support acquisition economics ^{[3]FoodNavigator. "Zoe staff cuts reflect industry-wide customer churn challenge." foodnavigator.com}.

Enterprise adoption has a different constraint: nutrition AI must compete with other health and well-being priorities within fixed benefit allocations. Vendors therefore need to show where their service complements existing chronic-condition programs, registered-dietitian networks, or pharmacy benefits rather than presenting as an isolated wellness add-on. Contract expansion is likely to favor operators that can document economic and clinical relevance ^{[4]Business Group on Health. "15th Annual Employer-Sponsored Health and Well-being Survey." businessgrouphealth.org}.

Clinical adoption is further limited by uneven validation standards across dietary AI, diagnostics, continuous glucose monitoring, and supplement recommendations. A systematic review found a limited body of eligible studies evaluating AI-generated dietary interventions, underscoring the gap between technological capability and broadly established clinical evidence ^{[5]National Institutes of Health / PMC. "Artificial Intelligence Applications to Personalized Dietary Recommendations: A Systematic Review." pmc.ncbi.nlm.nih.gov}. This makes governance, validation, and clinician oversight material differentiators for institutional buyers.

Personalized Nutrition AI Platforms Market Segment Analysis

By Platform Type

Machine Learning (ML)-based Platforms

Machine learning (ML)-based platforms generated USD 840.0 million in 2025 and are projected to account for 20.0% of the market in 2035. Their installed base remains commercially important in weight management and dietary tracking, where established recommendation engines can be cost-effective. However, vendors will need to add richer interfaces and data-integration capabilities to avoid displacement by more adaptive architectures.

Large Language Model (LLM)/GenAI-based Platforms

Large language model (LLM)/GenAI-based platforms are projected to reach USD 11.92 billion by 2035 and expand at a 32.0% CAGR (2026-2035). Their advantage is not simply automated conversation; it is the ability to synthesize dietary behavior, biomarker inputs, and real-time context into a more continuous coaching experience. Enterprise adoption will depend on whether that flexibility can be delivered with reliable clinical controls.

Multi-Omics AI Systems

Multi-omics AI systems accounted for 15.0% of the market in 2025 and are projected to reach USD 4.76 billion by 2035. These platforms serve a premium segment where genomic, microbiome, and metabolomic inputs can support a more individualized proposition. Their expansion will be shaped by consumer willingness to purchase biological testing and by institutional confidence in the reproducibility of associated recommendations.

Predictive Analytics Platforms

Predictive analytics platforms generated USD 210.0 million in 2025 and are projected to hold 10.0% of the market in 2035. Their value is concentrated in risk stratification, adherence forecasting, and population-level intervention targeting. As predictive functions become embedded within broader platform stacks, standalone providers will need to differentiate through workflow integration and decision-support depth.

By Application

Meal Planning & Dietary Recommendations

Meal planning & dietary recommendations generated USD 525.0 million in 2025 and are projected to reach USD 5.24 billion by 2035. The personalized nutrition AI platforms market continues to rely on meal-level guidance as its most accessible user touchpoint. Product differentiation increasingly depends on how effectively recommendations reflect practical constraints such as preferences, food availability, schedule, and household behavior.

Personalized Supplement Recommendations

Personalized supplement recommendations represented 11.0% of the market in 2025 and are projected to reach USD 2.86 billion by 2035. This application benefits from a recurring product component that can strengthen revenue continuity relative to software-only coaching. Its long-term credibility, however, will depend on the quality of biomarker interpretation and the discipline of health-related claims.

Weight Management & Metabolic Health

Weight management & metabolic health accounted for 21.0% of the market in 2025 and is projected to grow at a 25.6% CAGR (2026-2035). The category is being repositioned by GLP-1 treatment adoption, with nutrition platforms increasingly serving as companions for dietary adequacy, behavior support, and post-treatment maintenance. That evolution raises the importance of clinical partnerships and medication-aware coaching.

Chronic Disease Management

Chronic disease management is projected to reach USD 6.67 billion by 2035 and expand at a 31.4% CAGR (2026-2035). The segment is attractive to health systems and payers because dietary support can be linked to high-cost cardiometabolic conditions. Vendors that can fit into referral pathways and outcomes-reporting processes are likely to have an advantage over consumer-only offerings.

Sports & Performance Nutrition

Sports & performance nutrition represented 10.0% of the market in 2025 and is projected to reach USD 2.14 billion by 2035. Demand is anchored in performance-oriented users seeking context-specific guidance for fueling, recovery, and hydration. Wearable integration is becoming particularly important because it connects nutrition advice to training load and physiological state.

Allergen & Food Sensitivity Management

Allergen & food sensitivity management accounted for 6.0% of the market in 2025 and is projected to grow at a 25.3% CAGR (2026-2035). The application is moving beyond static avoidance lists toward tools that interpret ingredient information, symptom patterns, and meal choices in real time. Trust, accuracy, and local food-data coverage will determine whether platforms can serve clinically sensitive use cases credibly.

By End User

Individuals & Consumers

Individuals & consumers generated USD 714.0 million in 2025 and are projected to account for 28.0% of the market in 2035. Consumer channels remain essential for data accumulation, brand building, and rapid product iteration. Their relative role is expected to evolve as institutional channels gain weight and platforms seek more durable reimbursement or employer-sponsored models.

Healthcare Providers

Healthcare providers are projected to reach USD 6.43 billion by 2035 and grow at a 29.5% CAGR (2026-2035). Providers are using nutrition AI to extend dietitian and care-team capacity across larger patient panels. Success in this segment requires interoperability, patient-data protection, clinician trust, and evidence that recommendations can be incorporated without adding workflow burden.

Fitness & Wellness Centers

Fitness & wellness centers generated USD 252.0 million in 2025 and are projected to represent 11.0% of the market in 2035. These customers use nutrition AI to deepen member engagement and complement coaching or recovery services. Vendors must demonstrate a level of personalization or service integration that consumers cannot easily obtain through lower-cost direct subscriptions.

Employers & Enterprises

Employers & enterprises accounted for 14.0% of the market in 2025 and are projected to reach USD 3.81 billion by 2035. Enterprise demand is increasingly tied to prevention, productivity, and chronic-condition benefit design rather than broad wellness messaging. Platforms that align enrollment, engagement, and outcomes data with employer benefit systems will be better positioned for scaled deployment.

Food & Beverage Manufacturers

Food & beverage manufacturers are projected to reach USD 2.62 billion by 2035 and expand at a 30.0% CAGR (2026-2035). Manufacturers are using personalized nutrition intelligence to inform product development, consumer engagement, and evidence-led health positioning. The value proposition depends on whether biological and behavioral insights can be translated into commercially usable formulation and marketing decisions.

Insurers & Health Plans

Insurers & health plans represented 5.0% of the market in 2025 and are projected to reach USD 1.19 billion by 2035. Although the segment begins from a smaller revenue base, payer adoption can influence reimbursement standards and channel access across the wider market. Platforms must make a credible case that targeted nutrition intervention can support risk reduction and lower avoidable costs.

Personalized Nutrition AI Platforms Market Regional Analysis

North America Personalized Nutrition AI Platforms Market Analysis

The personalized nutrition AI platforms market in North America generated USD 735.0 million in 2025 and is projected to reach USD 7.15 billion by 2035. The region combines deep digital-health investment, mature employer-benefit infrastructure, and a large pool of health-focused consumers. Its market development is increasingly tied to whether platform vendors can establish clinical and payer relevance alongside direct-to-consumer scale.

U.S.

The U.S. generated USD 696.5 million in 2025 and is projected to reach USD 6.65 billion by 2035. Its scale reflects the concentration of platform developers, employer health benefits, and chronic-condition management programs. Commercial momentum will favor solutions that can operate across consumer engagement and regulated clinical environments.

Canada

Canada accounted for 5.2% of North American revenue in 2025 and is projected to grow at a 29.3% CAGR (2026-2035). Provincial health-system interest in prevention and a growing digital-health ecosystem create an opening for platforms that can adapt to local privacy, procurement, and bilingual service requirements.

Europe Personalized Nutrition AI Platforms Market Analysis

Europe represented 27.5% of the market in 2025 and is projected to reach USD 5.72 billion by 2035. The region has strong scientific capabilities in genomics and microbiome research, but fragmented reimbursement systems and stringent data-protection requirements make local market execution essential. Vendors must balance scientific differentiation with country-specific commercialization strategies.

Germany

Germany generated USD 115.5 million in 2025 and is projected to reach USD 1.14 billion by 2035. Its preventive-health orientation, life-sciences base, and digital-health reimbursement environment support adoption of clinically positioned platforms. Providers that integrate with established medical and insurer ecosystems are likely to be more competitive than stand-alone wellness applications.

UK

The UK accounted for 26.0% of European revenue in 2025 and is projected to reach USD 1.48 billion by 2035. The market benefits from a concentration of science-led nutrition innovators and strong consumer familiarity with digital health. NHS engagement and evidence-generation partnerships could be decisive in determining how quickly platforms move beyond premium consumer positioning.

France

France generated USD 86.6 million in 2025 and is projected to account for 15.0% of European revenue in 2035. Localized recommendations that reflect French food culture, ingredient availability, and consumer expectations will be important to adoption. Employer programs and direct-to-consumer services provide near-term channels while clinical integration develops more gradually.

Asia Pacific Personalized Nutrition AI Platforms Market Analysis

Asia Pacific is projected to reach USD 9.06 billion by 2035 and expand at a 30.5% CAGR (2026-2035). The region's growth is supported by rising metabolic-health needs, mobile-first digital behavior, and broad openness to technology-mediated health services. Success will require localization across language, dietary practice, payment models, and platform ecosystems.

China

China accounted for 25.0% of Asia Pacific revenue in 2025 and is projected to reach USD 2.26 billion by 2035. Its large addressable population and mature digital ecosystem support consumer-scale nutrition engagement. Domestic platform integration and localization will be central to market access and sustained user relevance.

Japan

Japan generated USD 100.8 million in 2025 and is projected to grow at a 28.8% CAGR (2026-2035). Demand is shaped by longevity-oriented wellness practices, consumer interest in microbiome science, and an aging population. Platforms that accommodate Japanese food patterns and prevention priorities can develop a differentiated value proposition.

India

India is projected to reach USD 1.81 billion by 2035 and expand at a 32.6% CAGR (2026-2035). Rising cardiometabolic risk, rapid smartphone adoption, and a large domestic technology ecosystem create a substantial growth setting. Affordable, culturally relevant products will be more important than direct replication of premium Western subscription models.

South Korea

South Korea accounted for 13.0% of Asia Pacific revenue in 2025 and is projected to reach USD 1.17 billion by 2035. Strong digital adoption and interest in functional nutrition support demand for data-led dietary guidance. Wearable connectivity and health-tech export capabilities may also strengthen the country's role as a regional innovation market.

Latin America Personalized Nutrition AI Platforms Market Analysis

Latin America represented 4.5% of the market in 2025 and is projected to grow at a 28.8% CAGR (2026-2035). Rising obesity and diabetes prevalence support the long-term need for preventive nutrition tools, while smartphone access enables direct engagement. Affordability and limited reimbursement remain central constraints on near-term market development.

Brazil

Brazil generated USD 47.3 million in 2025 and is projected to account for 50.0% of Latin American revenue in 2035. Its large consumer base and expanding health-tech ecosystem make it the region's leading opportunity. Platform adoption will be supported by accessible pricing, local dietary relevance, and partnerships that improve trust in digital health services.

Mexico

Mexico accounted for 25.0% of Latin American revenue in 2025 and is projected to grow at a 28.9% CAGR (2026-2035). Chronic-disease needs and corporate wellness adoption offer a basis for expansion. Vendors that can connect consumer access with employer-sponsored programs may create more durable commercial pathways.

Middle East & Africa Personalized Nutrition AI Platforms Market Analysis

The Middle East & Africa personalized nutrition AI platforms market generated USD 63.0 million in 2025 and is projected to reach USD 715.0 million by 2035. Growth is concentrated in higher-income Gulf markets, where public health initiatives, digital-health spending, and metabolic-risk management are supporting adoption. Elsewhere, infrastructure and affordability will continue to shape the pace of penetration.

Saudi Arabia

Saudi Arabia accounted for 30.0% of Middle East & Africa revenue in 2025 and is projected to reach USD 200.0 million by 2035. Health-transformation initiatives and strong interest in digital wellness create favorable conditions for preventive nutrition offerings. Public-sector alignment and employer deployment can help providers move beyond affluent consumer niches.

UAE

The UAE generated USD 18.9 million in 2025 and is projected to account for 28.0% of Middle East & Africa revenue in 2035. Its role as a regional technology and wellness hub supports commercial testing and cross-border expansion. Providers will benefit from serving a diverse consumer population with localized, multilingual experiences.

South Africa

South Africa accounted for 20.0% of Middle East & Africa revenue in 2025 and is projected to grow at a 28.7% CAGR (2026-2035). Demand is developing through digitally connected urban consumers and private-healthcare interest in prevention. Mobile-first delivery and cost-sensitive service design will be particularly important for wider adoption.

Personalized Nutrition AI Platforms Market Share & Competitive Landscape

The personalized nutrition AI platforms market share remains fragmented, with the five leading companies collectively holding approximately 28.8% of global revenue in 2025. The structure reflects a market where behavioral coaching, diagnostics, supplements, food-as-medicine services, and AI decision support are still converging. Competitive advantage depends on data quality, clinical credibility, channel partnerships, and the ability to sustain user engagement.

Noom Inc. held approximately 20.0% of the market in 2025. Its behavioral-change orientation and expansion into metabolic-health support give it a meaningful position as health plans seek scalable programs that combine nutrition, habit formation, and care navigation. The company's competitive test is whether its consumer engagement capabilities can translate into repeatable payer outcomes.

ZOE Limited held approximately 3.2% of the market in 2025. Its multi-biomarker approach, combining dietary responses with biological testing, provides a science-led differentiation strategy. The company's future position will depend on balancing premium personalization with an operating model that can withstand the retention pressures affecting subscription-based nutrition services.

Viome Life Sciences held approximately 2.1% of the market in 2025. Its RNA-based microbiome and biological-analysis proposition positions it at the intersection of diagnostics, personalized nutrition, and supplements. The company's opportunity lies in converting complex biological data into recommendations that users and institutional partners can understand and trust.

Persona Nutrition leverages Nestle's nutrition expertise and distribution reach to position personalized supplements within a broader consumer-health ecosystem. InsideTracker combines biomarkers, genetics, wearable inputs, and AI-guided coaching, giving it relevance where users seek performance, metabolic, or preventive-health applications. Other participants, including Lumen Technologies, Bioniq, Nutrigenomix Inc., FoodMarble, myDNA, Elo Health, January AI, GenoPalate, Season Health, and Baze, compete through specialized data sources, clinical models, or nutrition-delivery formats.

Recent Industry Developments

On April 23, 2025, Nourish announced a USD 70 million Series B financing round to support expansion of its virtual nutrition-care platform, provider network, AI capabilities, and payer relationships ^{[6]FierceHealthcare. "Nutrition counseling startup Nourish clinches $70M to expand services." fiercehealthcare.com}. The development signals continued investor interest in models that combine registered-dietitian delivery with reimbursable, technology-supported nutrition care.

On October 20, 2025, Highmark announced a collaboration with Noom to make its weight-management program available to nearly 2 million eligible members beginning in 2026 ^{[7]Highmark. "Highmark and Noom collaborate to improve member health through behavior change and personalized support." highmark.com}. The partnership illustrates how payer distribution can validate nutrition platforms that integrate behavior change, personalized support, and chronic-condition management.